Literature DB >> 29674586

Insurance coverage for genomic tests.

Kathryn A Phillips1,2,3, Julia R Trosman4, Patricia A Deverka5,6, Bruce Quinn7, Sean Tunis8, Peter J Neumann9, James D Chambers9, Louis P Garrison10, Michael P Douglas5, Christine B Weldon4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29674586      PMCID： PMC5991085          DOI： 10.1126/science.aas9268

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

1.  Private payers disagree with Medicare over medical device coverage about half the time.

Authors:  James D Chambers; Matthew Chenoweth; Teja Thorat; Peter J Neumann
Journal:  Health Aff (Millwood)       Date:  2015-08       Impact factor: 6.301

2.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

3.  Medicare's enduring struggle to define "reasonable and necessary" care.

Authors:  Peter J Neumann; James D Chambers
Journal:  N Engl J Med       Date:  2012-10-31       Impact factor: 91.245

4.  Payer coverage policies for multigene tests.

Authors:  Kathryn A Phillips; Patricia A Deverka; Julia R Trosman; Michael P Douglas; James D Chambers; Christine B Weldon; Andrew P Dervan
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

5.  Insurance for broad genomic tests in oncology.

Authors:  Rebecca Eisenberg; Harold Varmus
Journal:  Science       Date:  2017-12-01       Impact factor: 47.728
  5 in total
  6 in total

1.  How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

Authors:  Barbara J Evans; Gail Javitt; Ralph Hall; Megan Robertson; Pilar Ossorio; Susan M Wolf; Thomas Morgan; Ellen Wright Clayton
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

2.  How Can Law Support Development of Genomics and Precision Medicine to Advance Health Equity and Reduce Disparities?

Authors:  Susan M Wolf; Vence L Bonham; Marino A Bruce
Journal:  Ethn Dis       Date:  2019-12-12       Impact factor: 1.847

3.  New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare.

Authors:  K A Phillips; J R Trosman; C B Weldon; M P Douglas
Journal:  JCO Precis Oncol       Date:  2018-11-08

4.  The Global Market for Next-Generation Sequencing Tests Continues Its Torrid Pace.

Authors:  Kathryn A Phillips; Michael P Douglas
Journal:  J Precis Med       Date:  2018-10

5.  Stanford's Biodesign Innovation program: Teaching opportunities for value-driven innovation in surgery.

Authors:  Dimitri A Augustin; Cynthia A Yock; James Wall; Linda Lucian; Thomas Krummel; Jan B Pietzsch; Dan E Azagury
Journal:  Surgery       Date:  2019-12-18       Impact factor: 3.982

6.  Sex-specific recombination patterns predict parent of origin for recurrent genomic disorders.

Authors:  Trenell J Mosley; H Richard Johnston; David J Cutler; Michael E Zwick; Jennifer G Mulle
Journal:  BMC Med Genomics       Date:  2021-06-09       Impact factor: 3.063
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.